PetCaseFinder

Peer-reviewed veterinary case report

Risk factors for poor outcome in Shiba dogs with chronic bowel disease

By Okanishi, Hiroki et al.·Published in Acta veterinaria Scandinavica·2013·Department of Veterinary Medicine, Japan·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: The characteristics of short- and long-term surviving Shiba dogs with chronic enteropathies and the risk factors for poor outcome.

Species:
dog

Plain-English summary

A group of 25 Shiba Inu dogs with chronic enteropathies (CE), which is a type of inflammatory bowel disease, was studied to understand their survival rates and factors affecting their outcomes. The dogs were divided into short-term survivors, who lived less than six months after diagnosis, and long-term survivors, who lived more than six months. Older dogs (over 7 years) and those with higher disease activity scores were more likely to have poor outcomes. While most dogs responded to initial treatment, about half of the long-term survivors eventually died due to a relapse of their symptoms. Regular follow-up is crucial for these dogs to monitor their condition.

People also search for: Shiba Inu chronic enteropathy treatment · dog inflammatory bowel disease symptoms · why is my dog vomiting after eating

Abstract

BACKGROUND: The objectives of this study were to investigate the differences in the characteristics of short- and long-term surviving dogs, and the factors that predict poor outcome in Shiba dogs with chronic enteropathies (CE). METHODS: A total of 25 Shiba dogs were included in this study, and classified as either short-term (≤6 months) survivors (Ss; n=16) or long-term (>6 months) survivors (Ls; n=9). The clinical and clinicopathological variables, histopathology, response to therapy, and outcomes were investigated between groups. Furthermore, these factors were tested for their ability to predict poor outcome. RESULTS: All CE dogs were diagnosed as having inflammatory bowel disease (IBD) with lymphocytic-plasmacytic enteritis (LPE). Age and canine inflammatory bowel disease activity index (CIBDAI) were significantly higher in the Ss group than in the Ls group (age: p = 0.035, CIBDAI: p = 0.018), as determined via univariate logistic regression analysis. According to receiver operator characteristic (ROC) curve analysis, the best predictors of poor outcome were age and CIBDAI, with the cutoffs determined as 7 years and 9 points, respectively. The majority of the cases (84%) responded to initial treatment; in particular, 75% of dogs in Ss group responded to therapy. The time to response (days) to the initial treatment in the Ss group (median 42.5 days, range: 20-91 days) was significantly shorter than that of the Ls group (median 285 days, range: 196-1026 days). Approximately half (55.5%) of the dogs in the Ls group died due to relapse of CE. CONCLUSIONS: This study suggested that there is a high risk of early mortality in Shiba dogs with CE, particularly if the dogs are older (>7 years) and have a high CIBDAI score (>9 points). There appears to be a possibility of early mortality even if the initial treatment was efficacious. Furthermore, Shiba dogs with CE that become less responsive to initial therapy in the short-term (approximately 3 months) are more likely to have an early mortality. Thus, it is necessary to follow-up Shiba dogs with CE in the long-term, as approximately half of the long-term survivors eventually died due to a relapse of the signs.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23594569/